Detecting Colorectal Cancer Early Saves Lives. Get the Blood Test that Finds it Early.ColonSentry® is a convenient blood test that uses advanced gene expression (mRNA) technology to help identify Colorectal Cancer (CRC) early, when it's most treatable (1).
|
About the ColonSentry Blood TestColonSentry, is the first liquid biopsy for CRC, using our patented Sentinel Principle Technology Platform and was validated in more than 9000 patients in North America and has been used on more than 100,000 patients nationwide. If your ColonSentry score is elevated, there is an increased probability you may have Colorectal Cancer. (1-3)
Benefits Include:
Why Get Tested? When Colorectal Cancer is found early, the five-year survival rate is 91%. When Colorectal Cancer is found late, the five-year survival rate is 14%. (4) |
|
References
- Chao S, Ying J, Liew G, et al. Blood RNA biomarker panel detects both left- and right-sided colorectal neoplasms: a case- control study. J Exp Clin Cancer Res. 2013 Jul 23;32:44.Yip KT, Das PK, Suria D, et al.
- Liew CC, Ma J, Tang HC, et al. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med. 2006 Mar;147(3):126-32.
- Marshall KW, Mohr S, Khettabi FE, et al. A blood-based biomarker panel for stratifying current risk for colorectal cancer. Int J Cancer. 2010 Mar 1;126(5):1177-86.
- Seer.cancer.gov Dec 2019 * 5-year Survival Rate
The ColonSentry® Test is intended for use in patients without a personal history of colorectal cancer, pre-cancerous polyps or inflammatory bowel disease. The ColonSentry® test was developed and its performance characteristics were determined by StageZero Life Sciences. It has not been cleared or approved by the U.S. Food and Drug Administration. This test is for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under CLIA as qualified to perform high complexity clinical laboratory testing. The ColonSentry test must be ordered by and used only in consultation with a healthcare provider.